MedPath
HSA Product

RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 37.5MG/VIAL

Product approved by Health Sciences Authority (SG)

Basic Information

RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 37.5MG/VIAL

INJECTION, SUSPENSION, EXTENDED RELEASE

Regulatory Information

SIN17184P

February 20, 2025

Prescription Only

Therapeutic

INTRAMUSCULAR

May 23, 2025

June 3, 2025

Company Information

Active Ingredients

Risperidone

Strength: 37.5mg/vial

© Copyright 2025. All Rights Reserved by MedPath